Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$12,843 Mln
Revenue (TTM)
$2,530 Mln
Net Profit (TTM)
$0 Mln
ROE
0.7 %
ROCE
-- %
P/E Ratio
29.6
P/B Ratio
28.5
Industry P/E
--
EV/EBITDA
22.6
Div. Yield
0 %
Debt to Equity
0.5
Book Value
$15.3
EPS
$15
Face value
--
Shares outstanding
28,381,283
CFO
$2,050.46 Mln
EBITDA
$1,684.51 Mln
Net Profit
$1,057.34 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medpace Holdings (MEDP)
| -19.7 | 0.9 | -20.5 | 42.0 | 35.4 | 22.1 | -- |
|
BSE Sensex
| -13.1 | -10.5 | -13.5 | -4.8 | 8.6 | 8.5 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Medpace Holdings (MEDP)
| 69.1 | 8.3 | 44.3 | -2.4 | 56.4 | 65.6 | 58.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medpace Holdings (MEDP)
|
451.2 | 12,842.8 | 2,530.2 | 451.1 | 21.3 | 70.2 | 29.6 | 28.5 |
| 57.8 | 7,888.0 | 1,091.0 | 202.3 | 31.6 | 31.3 | 35.2 | 13.9 | |
| 217.0 | 13,621.9 | 691.7 | -219.0 | -13.7 | 163.2 | -- | 14.6 | |
| 62.5 | 7,599.2 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 41.5 | 11,065.0 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.8 | 5.0 | |
| 84.6 | 11,173.1 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 61.6 | 7,485.8 | 1,396.6 | 316.9 | 59.8 | 153.6 | 24.7 | 153.4 | |
| 7.4 | 8,708.1 | 113.3 | -351.4 | -211.0 | 71.1 | -- | 0.0 | |
| 510.7 | 10,120.2 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 | |
| 290.1 | 8,308.2 | 0.0 | -303.3 | -- | -45.8 | -- | 9.5 |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development... process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Read more
Chairman & CEO
Dr. August James Troendle M.D.
Chairman & CEO
Dr. August James Troendle M.D.
Headquarters
Cincinnati, OH
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Medpace Holdings Inc (MEDP) is $451.20 (NASDAQ) as of 27-Mar-2026 16:00 EDT. Medpace Holdings Inc (MEDP) has given a return of 35.36% in the last 3 years.
The P/E ratio of Medpace Holdings Inc (MEDP) is 29.60 times as on 20-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
37.35
|
36.70
|
|
2024
|
26.29
|
12.88
|
|
2023
|
34.68
|
17.55
|
|
2022
|
29.43
|
18.69
|
|
2021
|
45.48
|
8.68
|
The 52-week high and low of Medpace Holdings Inc (MEDP) are Rs 628.92 and Rs 250.05 as of 28-Mar-2026.
Medpace Holdings Inc (MEDP) has a market capitalisation of $ 12,843 Mln as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Medpace Holdings Inc (MEDP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-15.40
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.